Lack of pharmacodynamic and pharmacokinetic interaction between pantoprazole and phenprocoumon in man

European Journal of Clinical Pharmacology

Volumn 51, Issue 3-4, 1996, Pages 277-281

  Ehrlich, A ^a   Fuder, H ^a   Hartmann, M ^b   Wieckhorst, G ^a   Timmer, W ^a   Huber, R ^b   Birkel, M ^a   Bliesath, H ^b   Steinijans, V W ^b   Wurst, W ^b   Lucker P W ^a  

^a Prof Dr Lucker GmbH   (Germany)

^b ALTANA PHARMA AG   (Germany)

Author keywords

oral anticoagulant phenprocoumon; pantoprazole; proton pump inhibitor drug interaction; pharmacodynamics; pharmacokinetics

Indexed keywords

CYTOCHROME P450; PANTOPRAZOLE; PHENPROCOUMON;

ADULT; AREA UNDER THE CURVE; ARTICLE; DRUG INTERACTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; PROTHROMBIN TIME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTICOAGULANTS; BENZIMIDAZOLES; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; HUMANS; MALE; OMEPRAZOLE; PHENPROCOUMON; PROTON PUMPS; STEREOISOMERISM; SULFOXIDES;

EID: 8044259003     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050198     Document Type: Article

References (22)

1. Benet LZ, Zech K (1994) Pharmacokinetics - a relevant factor for the choice of a drug? Aliment Pharmacol Ther 8 (Suppl 1):25-32
2. Bliesath H, Huber R, Hartmann M, Lühmann R, Wurst W (1994) Dose linearity of the pharmacokinetics of the new H+/K+-ATPase inhibitor pantoprazole after single intravenous administration. Int J Clin Pharmacol Ther 32:44-50
3. Bliesath H, Huber R, Steinijans VW, Koch HJ, Wurst W, Mascher H (1996) Lack of pharmacokinetic interaction between pantoprazole and diclofenac. Int J Clin Pharmacol Ther 34:139-151
4. Brunton LL (1996) Agents for control of gastric acidity and treatment of peptic ulcers. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A, (eds) Goodman and Gilman's The pharmacological basis of therapeutics. McGraw-Hill, New York, p 909
5. Duursema L, Müller FO, Schall R, Middle MV, Hundt HKL, Groenewoud G, Steinijans VW, Bliesath H (1995) Lack of effect of pantoprazole on the pharmacodynamics and pharmacokinetics of warfarin. Br J Clin Pharmacol 39:700-703
6. Fuhr U, Weiss M, Kroemer HK, Neugebauer G, Rameis H, Weber W, Woodcock BG (1994) Pharmakokinetische Arzneimittelinteraktionen: Mechanismus und gezielte Prüfung. Klin Pharmakol Akt 1:5-14
7. Gugler R (1979) Arzneimittelwechselwirkungen in der Therapie mit Cumarin-Derivaten. Internist 20:238-244
8. Halpert JR (1995) Structural basis of selective cytochrome P450 inhibition. Ann Rev Pharmacol Toxicol 35:29-53
9. Hartmann M, Bliesath H, Zech K, Koch H, Steinijans VW, Wurst W (1995) Lack of induction of CYPIA2 activity in man by pantoprazole. Gut 37 (Suppl 2):A32
10. Hewick DS, Shepherd AMM (1976) The plasma elimination of the enantiomers of phenprocoumon in man. J Pharm Pharmacol 28:257-258
11. Huber R, Bliesath H, Hartmann M, Koch HJ, Steinijans VW, Mascher H, Wurst W (1996) Pantoprazole does not interact with the pharmacokinetics of carbamazepine. Gastroenterology 110 (Suppl):A 137
12. Jähnchen F, Meinertz T, Gilfrich HJ (1976) The enantiomers of phenprocoumon: pharmacodynamic and pharmacokinetic studies. Clin Pharmacol Ther 20:342-349
13. Koch HJ, Hartmann M, Bliesath H, Huber R, Steinijans VW, Mascher H, Wurst W (1996) Pantoprazole has no influence on steady state pharmacokinetics and pharmacodynamics of metoprolol in healthy volunteers. Int J Clin Pharmacol Ther 34:420-423
14. MacLeod SM, Sellers EM (1976) Pharmacodynamic and pharmacokinetic drug interactions with coumarin anticoagulants. Drugs 11:461-470
15. Mey C de, Meineke I, Steinijans VW, Huber R, Hartmann M, Bliesath H, Wurst W (1994) Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction. Int J Clin Pharmacol Ther 32:98-106
16. Oguri K, Yamada H, Yoshimura H (1994) Regiochemistry of cytochrome P450 isoenzymes. Ann Rev Pharmacol Toxicol 34:251-279
17. Pue MA, Laroche J, Meineke I, de Mey C (1993) Pharmacokinetics of pantoprazole following single intravenous and oral administration to healthy male subjects. Eur J Clin Pharmacol 44:575-578
18. Schulz H-U, Hartmann M, Steinijans VW, Huber R, Lührmann B, Bliesath H, Wurst W (1991) Lack of influence of pantoprazole on the disposition kinetics of theophylline in man. Int J Clin Pharmacol Ther Toxicol 9:369-375
19. Steinijans VW, Hartmann M, Huber R, Radtke HW (1991) Lack of pharmacokinetic interaction as an equivalence problem. Int J Clin Pharmacol Ther Toxicol 29:323-328
20. Steinijans VW, Huber R, Hartmann M, Zech K, Bliesath H, Wurst W, Radtke HW (1994) Lack of pantoprazole drug interaction in man. Int J Clin Pharmacol Ther 32:385-399
21. Tucker GT (1992) The rational selection of drug interaction studies: implications of recent advances in drug metabolism. Int J Clin Pharmacol Ther Toxicol 30:550-553
22. Tucker GT (1994) The interaction of proton pump inhibitors with cytochromes P450. Aliment Pharmacol Ther 8 (Suppl 1):33-38